Prognosis
FDA Clears Pfizer Shot for Teens; U.S. Cases Slow: Virus Update
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
The U.S. Food and Drug Administration approved the use of Pfizer-BioNTech vaccine for children aged 12 to 15. The number of new cases in U.S. rose last week at the slowest pace since the pandemic began, as more Americans are vaccinated and the nation recovers from a winter spike fueled by holiday travel.